Biomaterial adjuvant effect is attenuated by anti-inflammatory drug delivery or material selection
- 15 September 2010
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 146 (3), 341-348
- https://doi.org/10.1016/j.jconrel.2010.05.032
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Application of chitosan microspheres for nasal delivery of vaccinesBiotechnology Advances, 2009
- Current advances in research and clinical applications of PLGA-based nanotechnologyExpert Review of Molecular Diagnostics, 2009
- Past, Present, and Future Technologies for Oral Delivery of Therapeutic ProteinsJournal of Pharmaceutical Sciences, 2008
- Differential regulation of C-type lectin expression on tolerogenic dendritic cell subsetsImmunobiology, 2006
- Dendritic Cells Activated by Lipopolysaccharide after Dexamethasone Treatment Induce Donor-Specific Allograft HyporesponsivenessTransplantation, 2006
- Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypesMolecular Immunology, 2005
- Influence of immunosuppressive drugs on dendritic cellsTransplant Immunology, 2003
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Costimulatory molecules in the developing human gastrointestinal tract: A pathway for fetal allergen primingJournal of Allergy and Clinical Immunology, 2001
- CD4+ T CELL MEDIATED DESTRUCTION OF XENOGRAFTS WITHIN CELL-IMPERMEABLE MEMBRANES IN THE ABSENCE OF CD8+ T CELLS AND B CELLS1Transplantation, 1996